The pharmacological susceptibility of hERG to blockade by a variety of structurally diverse drugs underlies the drug-induced form of acquired long-QT syndrome (aLQTs), which could lead to Torsades de Pointes (TdP), a life-threatening disturbance of heart's rhythm [9,10]. The gene discussed is KCNH2; the disease is torsades de pointes.